Janney Montgomery Scott LLC raised its stake in Danaher Corporation (NYSE:DHR – Free Report) by 21.0% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 219,528 shares of the conglomerate’s stock after buying an additional 38,125 shares during the period. Janney Montgomery Scott LLC’s holdings in Danaher were worth $41,623,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently modified their holdings of DHR. JPL Wealth Management LLC acquired a new stake in shares of Danaher during the 3rd quarter valued at $25,000. Elevated Capital Advisors LLC acquired a new position in Danaher in the 4th quarter worth about $26,000. WFA of San Diego LLC bought a new position in Danaher in the second quarter valued at about $26,000. Hilton Head Capital Partners LLC bought a new position in Danaher in the fourth quarter valued at about $27,000. Finally, Clal Insurance Enterprises Holdings Ltd boosted its stake in shares of Danaher by 71.6% during the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock valued at $29,000 after purchasing an additional 53 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.
Wall Street Analysts Forecast Growth
DHR has been the subject of several recent research reports. Rothschild & Co Redburn set a $205.00 price target on shares of Danaher in a research report on Friday, April 17th. Wells Fargo & Company decreased their price objective on Danaher from $240.00 to $212.00 and set an “equal weight” rating for the company in a report on Wednesday, April 22nd. Jefferies Financial Group reaffirmed a “buy” rating and set a $245.00 target price on shares of Danaher in a research report on Tuesday, April 21st. UBS Group cut their target price on Danaher from $270.00 to $250.00 and set a “buy” rating on the stock in a report on Wednesday, April 22nd. Finally, Morgan Stanley reduced their price target on Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $233.61.
Danaher Stock Down 0.3%
Shares of NYSE:DHR opened at $195.67 on Monday. The company has a market capitalization of $138.49 billion, a price-to-earnings ratio of 37.85, a P/E/G ratio of 2.50 and a beta of 0.81. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52. The business’s 50-day moving average is $178.81 and its 200-day moving average is $201.53. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80.
Danaher (NYSE:DHR – Get Free Report) last released its earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, topping the consensus estimate of $1.94 by $0.12. The business had revenue of $5.95 billion during the quarter, compared to analysts’ expectations of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The firm’s revenue was up 3.7% on a year-over-year basis. During the same quarter last year, the firm posted $1.88 earnings per share. Equities research analysts predict that Danaher Corporation will post 8.44 earnings per share for the current year.
Danaher Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Friday, June 26th. Danaher’s dividend payout ratio is presently 30.95%.
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Further Reading
- Five stocks we like better than Danaher
- As Stablecoins Keep Growing, These 2 Stocks Benefit
- Apple Just Handed These 4 Memory Stocks Their Best News of the Year
- Costco’s Secret Growth Engine May Be Running Out of Gas
- Why Alphabet’s Pullback May Be an Opportunity in Disguise
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
